Chad Messer
Stock Analyst at Lake Street
(0.52)
# 3,992
Out of 4,944 analysts
25
Total ratings
32%
Success rate
-23.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COYA Coya Therapeutics | Initiates: Buy | $16 | $6.05 | +164.45% | 1 | Jul 9, 2025 | |
| BOLT Bolt Biotherapeutics | Initiates: Buy | $80 | $5.78 | +1,285.28% | 1 | May 20, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $4.64 | +439.37% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $10.25 | +124.39% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.84 | +932.61% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $1.93 | +5,806.74% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $51.60 | -3.10% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $35.61 | +34.79% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $38.27 | -21.61% | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | $50 | $46.18 | +8.27% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $12.15 | +138.68% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.74 | +476.37% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $42.15 | +104.03% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $4.14 | +1,711.59% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $10.76 | +308.92% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $19.26 | +761.89% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $3.33 | +441.35% | 1 | May 5, 2020 |
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $6.05
Upside: +164.45%
Bolt Biotherapeutics
May 20, 2025
Initiates: Buy
Price Target: $80
Current: $5.78
Upside: +1,285.28%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $4.64
Upside: +439.37%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $10.25
Upside: +124.39%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.84
Upside: +932.61%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $1.93
Upside: +5,806.74%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $51.60
Upside: -3.10%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $35.61
Upside: +34.79%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $38.27
Upside: -21.61%
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $46.18
Upside: +8.27%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $12.15
Upside: +138.68%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $1.74
Upside: +476.37%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $42.15
Upside: +104.03%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $4.14
Upside: +1,711.59%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $10.76
Upside: +308.92%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $19.26
Upside: +761.89%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $3.33
Upside: +441.35%